Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations.
Int J Hematol
; 106(5): 704-710, 2017 Nov.
Article
in En
| MEDLINE
| ID: mdl-28550352
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Factor VIII
/
Hemophilia A
/
Hemorrhage
Type of study:
Clinical_trials
/
Etiology_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Hematol
Journal subject:
HEMATOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan